Tech stocks are on the run again this year, with investors drawn both to the promise of artificial intelligence (AI) and the safe haven appeal of large tech companies with cash-heavy balance sheets. But how have high-dividend-paying tech stocks fared over the long term? | Read more >
SIVB became vulnerable—not by making bad loans, but by buying long-dated bonds prior to the recent rise in interest rates. SIVB’s deposit base was dominated by tech companies with balances well above the FDIC guarantee. It was the perfect setup for a bank run. | Read more >
Embracing uncertainty leads investors away from portfolios tailor-made for specific scenarios and towards solutions that control risk and offer likely returns, even in volatile times. | Read more >
Investors who ride out periods of equity market volatility have been well rewarded by sticking with high-yield stocks. Yet, “How am I doing?” remains a fair question from savers. With gyrating stock prices, there is no easy answer, and the question becomes more pointed as interest rates rise. | Read more >
The current situation is very uncertain. Our view is that the best approach is to stick with companies that are maintaining high levels of free cash flow while others are faltering. These companies should be able to continue to pay high and rising dividends, in our opinion. | Read more >
Military conflict inserts a new set of risks into the global market, just as investors were anticipating an economic rebound from the easing of COVID restrictions. Given the risks we have discussed and the market’s rocky start to the year, a fair question to ask is, “How do income stocks perform in down markets?” | Read more >
Despite the daily barrage of negative headlines, we still believe that we are months, rather than years, away from the end of the pandemic dominating daily behavior. | Read more >
The case for optimism centers on the remarkable strength of both the consumer and business sectors. | Read more >
Income investing does involve having general views on the future, but ultimate success is much more dependent on the power of compounding than 20/20 foresight. | Read more >
The news coming out of Pfizer’s vaccine trials on November 9th was truly spectacular and triggered a meaningful shift in the stock market. | Read more >